Welcome to our dedicated page for DHBCU news (Ticker: DHBCU), a resource for investors and traders seeking the latest updates and insights on DHBCU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DHBCU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DHBCU's position in the market.
On December 8, 2022, DHB Capital Corp. stockholders approved a Charter Amendment allowing the redemption of all outstanding public shares before December 30, 2022. Subsequently, the Board set December 9, 2022, as the termination date. The company requested the Nasdaq to suspend trading of its securities ahead of their expected delisting on December 12, 2022. Approximately 27.1 million shares were redeemed at about $10.10 per share, totaling roughly $273.7 million. Post-redemption, only 1.6 million shares will remain outstanding, with an estimated total redemption amount of $16.5 million.
DHB Capital Corp. (Nasdaq: DHBCU) announced that starting April 22, 2021, holders of the 28,750,000 units from its IPO can separately trade Class A common stock and warrants. The Class A shares will trade under the symbol 'DHBC' and the warrants under 'DHBCW' on Nasdaq. Units not separated will continue to trade as 'DHBCU.' A registration statement was filed with the SEC, effective March 1, 2021. The Company aims to pursue mergers and acquisitions, focusing on financial services.
DHB Capital Corp. (Nasdaq: DHBCU) has successfully closed the issuance of an additional 3,750,000 units through the full exercise of the underwriters' over-allotment option from its IPO. This action generated $37,500,000 in gross proceeds, bringing the total to $287,500,000. The units, which commenced trading on March 2, 2021, comprise one share of Class A common stock and one-third of a redeemable warrant, with each warrant allowing purchase of a share at $11.50. The company aims to focus on business combinations in the financial services sector.
DHB Capital Corp. (Nasdaq: DHBCU) has successfully completed its initial public offering, raising $250 million by issuing 25 million units at $10 each. The units, consisting of one share of Class A common stock and one-third of a warrant, commenced trading on Nasdaq on March 2, 2021. The company aims to pursue mergers or acquisitions primarily in the financial services sector. Underwriters have a 45-day option to purchase an additional 3.75 million units to cover over-allotments.
DHB Capital Corp. announced the pricing of its initial public offering (IPO) of 25 million units at $10.00 each, slated to begin trading on Nasdaq under the ticker DHBCU on March 2, 2021. Each unit includes one share of Class A common stock and one-third of a redeemable warrant, which allows the purchase of common stock at $11.50 per share. The company, a blank check entity, targets mergers in the financial services sector. The underwriters, BofA Securities and RBC Capital Markets, have a 45-day option to buy an additional 3.75 million units.
FAQ
What is the market cap of DHBCU (DHBCU)?
